[go: up one dir, main page]

Onychomycosis

"Onychomycosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
A fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS.


expand / collapse Publications
This graph shows the total number of publications written about "Onychomycosis" by people in this website by year, and whether "Onychomycosis" was a major or minor topic of these publications.
Below are the most recent publications written about "Onychomycosis" by people in Profiles.
  1. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients. J Drugs Dermatol. 2020 Sep 01; 19(9):867-872.
    View in: PubMed
  2. Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events. Dermatol Online J. 2020 Jul 15; 26(7).
    View in: PubMed
  3. Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 study. J Am Acad Dermatol. 2021 Apr; 84(4):1140-1142.
    View in: PubMed
  4. Cross-Linked Fluorescent Supramolecular Nanoparticles for Intradermal Controlled Release of Antifungal Drug-A Therapeutic Approach for Onychomycosis. ACS Nano. 2018 07 24; 12(7):6851-6859.
    View in: PubMed
  5. In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis. Antimicrob Agents Chemother. 2018 01; 62(1).
    View in: PubMed
  6. Pediatric Onychomycosis: The Emerging Role of Topical Therapy. J Drugs Dermatol. 2017 02 01; 16(2):105-109.
    View in: PubMed
  7. Over-the-counter and natural remedies for onychomycosis: do they really work? Cutis. 2016 Nov; 98(5):E16-E25.
    View in: PubMed
  8. Epidemiologic Analysis of Onychomycosis in the San Diego Pediatric Population. Pediatr Dermatol. 2017 Jan; 34(1):46-49.
    View in: PubMed
  9. Antifungal ME1111 in vitro human onychopharmacokinetics. Drug Dev Ind Pharm. 2017 Jan; 43(1):22-29.
    View in: PubMed
  10. Emerging therapies for the treatment of ungual onychomycosis. Drug Dev Ind Pharm. 2015; 41(10):1575-81.
    View in: PubMed